Bayer AG (BAYRY)
7.272
-0.10
(-1.32%)
USD |
OTCM |
Apr 24, 14:34
Bayer Shareholders Equity (Quarterly): 36.40B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 36.40B |
September 30, 2023 | 35.33B |
June 30, 2023 | 40.15B |
March 31, 2023 | 44.56B |
December 31, 2022 | 41.58B |
September 30, 2022 | 40.57B |
June 30, 2022 | 39.71B |
March 31, 2022 | 41.78B |
December 31, 2021 | 37.39B |
September 30, 2021 | 36.08B |
June 30, 2021 | 36.16B |
March 31, 2021 | 40.55B |
December 31, 2020 | 37.54B |
September 30, 2020 | 36.78B |
June 30, 2020 | 40.16B |
March 31, 2020 | 53.61B |
December 31, 2019 | 52.93B |
September 30, 2019 | 50.29B |
June 30, 2019 | 50.91B |
March 31, 2019 | 53.80B |
December 31, 2018 | 52.50B |
September 30, 2018 | 58.38B |
June 30, 2018 | 54.51B |
March 31, 2018 | 47.25B |
December 31, 2017 | 44.15B |
Date | Value |
---|---|
September 30, 2017 | 43.82B |
June 30, 2017 | 37.35B |
March 31, 2017 | 35.92B |
December 31, 2016 | 32.07B |
September 30, 2016 | 26.25B |
June 30, 2016 | 25.27B |
March 31, 2016 | 26.77B |
December 31, 2015 | 26.53B |
September 30, 2015 | 25.30B |
June 30, 2015 | 25.01B |
March 31, 2015 | 23.54B |
December 31, 2014 | 24.45B |
September 30, 2014 | 25.62B |
June 30, 2014 | 26.53B |
March 31, 2014 | 28.89B |
December 31, 2013 | 28.61B |
September 30, 2013 | 27.05B |
June 30, 2013 | 25.28B |
March 31, 2013 | 25.21B |
December 31, 2012 | 24.40B |
September 30, 2012 | 24.07B |
June 30, 2012 | 23.01B |
March 31, 2012 | 26.63B |
December 31, 2011 | 24.89B |
September 30, 2011 | 25.74B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
35.33B
Minimum
Sep 2023
53.61B
Maximum
Mar 2020
41.71B
Average
40.16B
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
Affimed NV | 63.90M |
InflaRx NV | 113.39M |
MorphoSys AG | 54.22M |
BioNTech SE | 22.38B |
Immatics NV | 248.81M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 128.51B |
Total Liabilities (Quarterly) | 91.95B |
Debt to Equity Ratio | 1.264 |
Current Ratio | 1.275 |
Net Debt Paydown Yield | -25.38% |